Twitter
Linkedin-in

Gene Therapy Europe: Online

05 – 06 May 2021 | BST (UTC+1)
Part of the Cell Series
Gene Therapy Europe: Online
Cell UK: In-Person
3D Cell Culture Symposium
Book Now
Gene Therapy Europe
05 – 06 May 2021 | BST (UTC+1)
Our Gene Therapy Europe: Online congress features in-depth discussion on advanced analytical strategies and next-gen technologies to progress gene therapy development from discovery to clinical stages.
Download Agenda
Register

The programme brings together world leaders from international pharmaceutical organisations and leading biotechnology companies as well as globally active regulatory agencies to discuss the latest advances in gene therapy.

Gene Therapy Europe: Online

Benefits to attending include…

Engage in scientific discussions on the latest tools and technologies for gene therapy drug discovery and analytics

Gain insights into the innovative technologies in gene editing, including CRISPR, ZFNs and TALENS and the translation of these technologies to clinical research

Explore methods to accelerate drug development through translational gene therapy, with presentations focussing on modelling, prediction of response, biomarkers and surrogate endpoints

This Year's Agenda at a Glance

05 May – Day One

  • Track 1: Gene Therapy Discovery
  • Track 2: Gene Editing Technologies

06 May – Day Two

  • Track 3: Translational Gene Therapy
  • Track 4: Gene Therapy Analytics & Commercialisation

Pre-Event Webinars

You don't have to wait until May to get involved - register for our complimentary live webinars here.
Presented by our expert speakers, these webinars will give you advance insight into topics that will be covered at the event.

Key Speakers

The 2021 event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Below were some of the speakers of 2020’s NextGen Omics Series US: Virtual
Vibha Jawa

Vibha Jawa

Bristol-Myers Squibb

Takashi Kishimoto, Selecta Bio

Takashi Kishimoto

Selecta Biosciences

Ken Macnamara, AskBio

Ken Macnamara

Asklepios BioPharmaceutical Inc

Aron Stein photo

Aron Stein

Sangamo Therapeutics

David-Favre_-AskBio

David Favre

Asklepios BioPharmaceutical Inc

Ashish Dugar, Sarepta Therapeutics

Ashish Dugar

Sarepta Therapeutics

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of features and make the most of participation in a range of virtual experiences.

Virtual Conference Platform

Our fully featured platform offers an immersive conference experience, delivering all the benefits of an in-person event

Live and On-Demand Presentations

Benefit from the insight of our expert speakers via pre-recorded presentations and interactive live presentations

Digital Networking Opportunities

Connect directly with other registrants of event around the world through direct 1-2-1 chat, video chat and group discussion

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.
Download Brochure
"The number of available presentations allowed for a wider choice of sessions to attend, giving comfortable control over our own schedule. The variety of presenters, both academic and industrial as well as their varied backgrounds gave interesting variety in perspectives. The commercial stalls had ample space and didn’t feel crowded.”
Production ScientistBio-Rad Laboratories Ltd
“The stand was busy and we had several new leads. We spoke to people that are very difficult to get hold of normally.”
SalesChemometec
“The talks were very informative. From a vendors perspective, the booths were well positioned and there was plenty of breakout opportunities.”
EMEA Sales ManagerBrooks Life Sciences
"The speaker line-up and presentations were very good – there was good insights into status of gene and cell therapies. The opportunity for networking was great.”
Head of Launch PreparationBayer AG
“Interesting, new and reasonably well grouped with focussed sessions and high quality speakers. I also enjoyed the ‘group’ meal and co-location of the meeting.”
DirectorHead of Protein Sciences, UCB Pharma
“Good presentations, good program, well organized .”
Global Program Associate DirectorNovartis
Previous
Next
Content Hub Graphic
Oxford Global Content HUB
Access complementary resources including Webinars, Q&A Sessions, Newsletters and much more.
Carousel
Cell Series Post Event Report 2019
Event statistics, testimonials, feedback and 2020 early programme info
Webinar - David Schaffer, Uni Cali
Complimentary Webinar
Director of the Berkeley Stem Cell Center, David Schaffer: Engineering Defined, Scalable, 3D Biomaterial Culture Systems for Stem Cell Expansion & Differentation
Cell UK 2019 Newsletter Carousel
Cell Series Pre-Event Newsletter
Download industry insight from senior speakers and sponsors of this year's event
Webinar
Complimentary Webinar
Alison McVie-Wylie, Vice President of Clinical Development at Exonics Therapeutics: Preclinical Development For AAV Gene Therapy
Market Survey Carousel
Cell & Gene Therapy Market Survey 2019
Insights from industry experts on clinical development, manufacturing and commercialisation

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter
Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Download Brochure

Full details regarding Cell Series UK: Virtual are available for download in the Conference Brochure

Read Now